The Serological Relationship Between Yersinia Enterocolitica O9 and Escherichia Coli O157 Using Sera from Patients with Yersiniosis and Haemolytic Uraemic Syndrome

Overview

Journal Epidemiol Infect

Publisher Cambridge University Press

Specialties Infectious Diseases
Public Health

Date 1991 Oct 1

PMID 1936156

Citations 5

Authors

H Chart

T Cheasty

D Cope

R J GROSS

B Rowe

Affiliations

Soon will be listed here.

Abstract

Sera from patients with yersiniosis, shown to contain antibodies to Yersinia enterocolitica O9; and sera from patients with haemolytic uraemic syndrome (HUS) caused by Escherichia coli O157, were used to investigate serological cross-reactions between Y. enterocolitica O9 and E. coli O157. Lipopolysaccharide (LPS) was isolated from strains of Y. enterocolitica O9 and E. coli O157 and reacted with sera by immunoblotting and ELISA. Sera from patients with HUS contained antibodies to the LPS of E. coli O157 only; 80% of sera from patients with yersiniosis contained antibodies to the LPS of Y. enterocolitica O9 and E. coli O157. This one-way cross-reaction was also detected using hyperimmune rabbit antisera.

Citing Articles

Identification of a Campylobacter jejuni protein that cross-reacts with cholera toxin.

Albert M, Haridas S, Steer D, Dhaunsi G, Smith A, Adler B Infect Immun. 2007; 75(6):3070-3.

PMID: 17438040 PMC: 1932847. DOI: 10.1128/IAI.00139-07.

Escherichia coli O157 somatic antigen is present in an isolate of E. fergusonii.

Fegan N, Barlow R, Gobius K Curr Microbiol. 2006; 52(6):482-6.

PMID: 16732460 DOI: 10.1007/s00284-005-0447-6.

Microarray analysis of microbial virulence factors.

Chizhikov V, Rasooly A, Chumakov K, Levy D Appl Environ Microbiol. 2001; 67(7):3258-63.

PMID: 11425749 PMC: 93008. DOI: 10.1128/AEM.67.7.3258-3263.2001.

Evidence of persisting serum antibodies to Escherichia coli O157 lipopolysaccharide and Verocytotoxin in members of rural communities in England.

Evans J, Chalmers R, Chart H, Salmon R, Kench S, Coleman T Eur J Epidemiol. 2001; 16(10):885-9.

PMID: 11338118 DOI: 10.1023/a:1011072907877.

Escherichia coli serotype O157:H7: novel vehicles of infection and emergence of phenotypic variants.

Feng P Emerg Infect Dis. 1995; 1(2):47-52.

PMID: 8903158 PMC: 2626836. DOI: 10.3201/eid0102.950202.

References

Tsai C, Frasch C . A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem. 1982; 119(1):115-9. DOI: 10.1016/0003-2697(82)90673-x. View

Stuart F, Corbel M . Identification of a serological cross-reaction between Brucella abortus and Escherichia coli 0:157. Vet Rec. 1982; 110(9):202-3. DOI: 10.1136/vr.110.9.202-a. View

Caroff M, Bundle D, Perry M . Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype O:9. Eur J Biochem. 1984; 139(1):195-200. DOI: 10.1111/j.1432-1033.1984.tb07994.x. View

Griffiths E, Stevenson P, Thorpe R, Chart H . Naturally occurring antibodies in human sera that react with the iron-regulated outer membrane proteins of Escherichia coli. Infect Immun. 1985; 47(3):808-13. PMC: 261399. DOI: 10.1128/iai.47.3.808-813.1985. View

Perry M, MacLean L, Griffith D . Structure of the O-chain polysaccharide of the phenol-phase soluble lipopolysaccharide of Escherichia coli 0:157:H7. Biochem Cell Biol. 1986; 64(1):21-8. DOI: 10.1139/o86-004. View

Notenboom R, Borczyk A, Karmali M, Duncan L . Clinical relevance of a serological cross-reaction between Escherichia coli O157 and Brucella abortus. Lancet. 1987; 2(8561):745. DOI: 10.1016/s0140-6736(87)91106-8. View

Scotland S, Rowe B, Smith H, Willshaw G, GROSS R . Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J Med Microbiol. 1988; 25(4):237-43. DOI: 10.1099/00222615-25-4-237. View

Chart H, Scotland S, Rowe B . Bacterial antigenic cross-reactions and haemolytic uraemic syndrome. Lancet. 1988; 2(8609):510-1. DOI: 10.1016/s0140-6736(88)90156-0. View

Gilmour A, Walker S . Isolation and identification of Yersinia enterocolitica and the Yersinia enterocolitica-like bacteria. Soc Appl Bacteriol Symp Ser. 1988; 17:213S-236S. View

10.

Chart H, Scotland S, Rowe B . Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome. J Clin Microbiol. 1989; 27(2):285-90. PMC: 267293. DOI: 10.1128/jcm.27.2.285-290.1989. View

11.

Levin M, Walters M, BARRATT T . Hemolytic uremic syndrome. Adv Pediatr Infect Dis. 1989; 4:51-81. View

12.

Chart H, Scotland S, Smith H, Rowe B . Antibodies to Escherichia coli O157 in patients with haemorrhagic colitis and haemolytic uraemic syndrome. J Clin Pathol. 1989; 42(9):973-6. PMC: 501798. DOI: 10.1136/jcp.42.9.973. View

13.

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

14.

Corbell M . The serological relationship between Brucella spp., Yersinia enterocolitica serotype IX and Salmonella serotypes of Kauffmann-White group N. J Hyg (Lond). 1975; 75(1):151-71. PMC: 2130237. DOI: 10.1017/s0022172400047173. View

15.

Sandulache R, Marx A . Immunochemical studies on a Yersinia enterocolitica O:9 lipopolysaccharide cross-reacting with Brucella abortus and Vibrio cholerae extracts. Ann Microbiol (Paris). 1978; 129 B(3):425-35. View

16.

Lindberg A, Haeggman S, Karlson K, Carlsson H, Mair N . Enzyme immunoassay of the antibody response to Brucella and Yersinia enterocolitica 09 infections in humans. J Hyg (Lond). 1982; 88(2):295-307. PMC: 2133853. DOI: 10.1017/s0022172400070157. View

17.

Wray W, Boulikas T, Wray V, Hancock R . Silver staining of proteins in polyacrylamide gels. Anal Biochem. 1981; 118(1):197-203. DOI: 10.1016/0003-2697(81)90179-2. View

18.

Hitchcock P, Brown T . Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol. 1983; 154(1):269-77. PMC: 217456. DOI: 10.1128/jb.154.1.269-277.1983. View